BRCA1/2 mutations are indeed often associated with an increased number of tumor-infiltrating lymphocytes in different cancer types (108, 109, 115, 116) and tumor-associated inflammation in BRCA1-mutant breast cancer has significant positive prognostic value (108, 117). The gene discussed is BRCA1; the disease is neoplasm.